We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
-6.01%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$260M
AUM Growth
-$29.3M
Cap. Flow
-$7.65M
Cap. Flow %
-2.94%
Top 10 Hldgs %
46.96%
Holding
520
New
21
Increased
42
Reduced
95
Closed
8

Top Sells

Rank Stock Value
1
ON icon
ON Semiconductor
ON
+$659K
2
NVDA icon
NVIDIA
NVDA
+$651K
3
MSFT icon
Microsoft
MSFT
+$576K
4
TGT icon
Target
TGT
+$552K
5
AAPL icon
Apple
AAPL
+$465K

Sector Composition

Rank Sector Weight
1 Technology 45.84%
2 Consumer Staples 9.63%
3 Healthcare 8.6%
4 Financials 7%
5 Industrials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDIV icon
426
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$3.57K ﹤0.01%
100
GTLB icon
427
GitLab
GTLB
$5.28B
$3.52K ﹤0.01%
+75
New +$4.59K
UAL icon
428
United Airlines
UAL
$38.4B
$3.45K ﹤0.01%
50
GBTC icon
429
Grayscale Bitcoin Trust
GBTC
$9.64B
$3.26K ﹤0.01%
50
LNTH icon
430
Lantheus
LNTH
$6.82B
$3.03K ﹤0.01%
31
IVOO icon
431
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
$2.96K ﹤0.01%
30
MBB icon
432
iShares MBS ETF
MBB
$39B
$2.81K ﹤0.01%
30
ECG
433
Everus Construction Group
ECG
$6.63B
$2.78K ﹤0.01%
75
SLYV icon
434
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$2.74K ﹤0.01%
35
AGG icon
435
iShares Core US Aggregate Bond ETF
AGG
$138B
$2.67K ﹤0.01%
27
JAZZ icon
436
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.61K ﹤0.01%
21
BG icon
437
Bunge Global
BG
$23.6B
$2.6K ﹤0.01%
34
VOO icon
438
Vanguard S&P 500 ETF
VOO
$968B
$2.57K ﹤0.01%
5
+4
+400% +$2.16K
M icon
439
Macy's
M
$6.15B
$2.55K ﹤0.01%
200
REGN icon
440
Regeneron Pharmaceuticals
REGN
$68.8B
$2.54K ﹤0.01%
4
ISTB icon
441
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.08B
$2.42K ﹤0.01%
50
HYG icon
442
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$2.37K ﹤0.01%
30
NMM icon
443
Navios Maritime Partners
NMM
$2.25B
$2.16K ﹤0.01%
55
TAK icon
444
Takeda Pharmaceutical
TAK
$55.1B
$2.16K ﹤0.01%
145
IPG
445
DELISTED
Interpublic Group of Companies
IPG
$2.06K ﹤0.01%
76
XPH icon
446
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
$1.98K ﹤0.01%
45
TNDM icon
447
Tandem Diabetes Care
TNDM
$1.17B
$1.92K ﹤0.01%
100
SOLV icon
448
Solventum
SOLV
$13.5B
$1.67K ﹤0.01%
22
VGT icon
449
Vanguard Information Technology ETF
VGT
$139B
$1.63K ﹤0.01%
+24
New +$1.81K
XBI icon
450
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$1.62K ﹤0.01%
20

Similar funds

Front Row Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Front Row Advisors held 520 positions worth $260M, down 10% from $290M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Front Row Advisors's Q1 2025 filing shows 21 new, 42 increased, 95 reduced and 8 closed positions. Its largest new stake was Entegris: 2,199 shares worth $192K. The largest sale was ON Semiconductor, an estimated $659K.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 50% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Front Row Advisors's largest Q1 2025 buy was Entegris: 2,199 shares worth $192K.
  • Front Row Advisors added most to Old Dominion Freight Line in Q1 2025, an estimated $93.3K increase.
  • Front Row Advisors's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $651K.
  • Front Row Advisors fully exited ON Semiconductor in Q1 2025, selling an estimated $659K.
  • Front Row Advisors's ten largest holdings make up 47% of its $260M portfolio in Q1 2025.
  • Front Row Advisors opened 21 new positions and closed 8 in Q1 2025.
  • Front Row Advisors's portfolio value fell 10% quarter-over-quarter to $260M.

Based on Front Row Advisors's 13F filing for Q1 2025, filed 15 May 2025.